SOURCE: Full Spectrum Software

July 14, 2010 03:15 ET

Andrew Dallas, CEO, Full Spectrum Software, Publishes Another Breakthrough New Article on Software Engineering for Medical Device Makers

SOUTHBOROUGH, MA--(Marketwire - July 14, 2010) -  Andrew Dallas, CEO of Full Spectrum Software, a life science and medical device custom software developer, has published a major new article in Medical Device and Diagnostic Industry magazine. The article notes that some medical device companies are overreacting to more stringent FDA oversight by creating excessive test documentation, sometimes at the expense of overall software quality. Life science and medical device custom software developer Full Spectrum Software has been observing a disturbing trend. Andrew Dallas, noted author, thought leader in medical device software development and CEO of Full Spectrum Software, has written a breakthrough analysis of the trend towards creating excessive V&V (Verification and Validation) documentation in response to more stringent scrutiny by the FDA. The article, titled "V&V May Be Hazardous to Software Quality," is published by Canon Communication's Medical Device and Diagnostic Industry magazine. Medical Device and Diagnostic Industry is the only peer reviewed trade magazine in the medical device industry and is the authoritative source for technology articles for medical makers. You can read the article by clicking here.

With changes at the FDA, many medical device makers have responded by dramatically increasing the complexity of their V&V efforts. Verification and Validation is required for FDA controlled software. Andrew Dallas, who is widely considered a national authority on software methodology for medical device software, offers a thought provoking analysis of the trend towards increasing the amount of Verification and Validation and the impact on medical device software quality. In his dual roles as both CEO and CTO of Full Spectrum Software, Andrew Dallas brings a unique perspective to his body of published work. 

Often controversial, Andrew Dallas writes with the unique perspective and authority of both an executive of a major medical device software developer as well as a hands-on software leader working with some of the most sophisticated medical device software ever developed. Andrew Dallas has been leading teams of software and quality assurance engineers for nearly 20 years in projects ranging from designing and developing software for devices that implant deep brain electrodes for the treatment of neurological disorders to advanced radiation therapy systems. More information on Full Spectrum Software can be found on their website by clicking here.

Contact Information

  • Contact Information
    Ken Carson
    Vice President, Client Services
    508-620-6400 X 208
    Email Contact


Keyword Cloud